PharmaCyte Biotech Inc (PMCB)

[BioNewton]

If PMCB's treatment is shrinking tumors and improving quality of life, the FDA is not going to let dying patients wait any longer. The drug, Ifosfamide is already an FDA approved drug. So, if CiaB shows it is safe AGAIN, that it stays where it is put AGAIN and it does the job AGAIN, the FDA will definitely approve it for breakthrough therapy.